Riskpilot← Back to searchSign inGet full accessFREDRIKSTAD HJERTESENTER AS
ASActiveOrg 916103328Kråkerøyveien 2B, 1671 KråkerøyMedical specialists activities · NACE 8622Est. 20151 employees
Revenue 2024
NOK 7M
-16% vs 2023
EBITDA margin
52.8%
-16% vs 2023
Equity ratio
88.3%
Financial strength
Net profit 2024
NOK 3,4M
+3% vs 2023
| Revenue | NOK 7M | -16% |
| EBITDA | NOK 3,7M | -16% |
| Net profit | NOK 3,4M | +3% |
| Total assets | NOK 17,1M | +22% |
| Equity | NOK 15,1M | +29% |
| Employees | 1 | — |
Legal name
FREDRIKSTAD HJERTESENTER AS
Org number
916103328
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
20. oktober 2015
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Hjerteutredning og medisinsk behandling, konsulentvirksomhet og hva som naturlig står i forbindelse med dette.
Address
Kråkerøyveien 2B, 1671 Kråkerøy
Phone
+4793818938
Email
post@fredrikstadhjertesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 6 485 | 6 917 | 6 909 | 8 315 | 7 005 |
| Staff expenses | −663 | −660 | −303 | −311 | −724 |
| EBITDA | 4 463 | 4 838 | 4 569 | 4 398 | 3 696 |
| Depreciation & amort. | −63 | −49 | −141 | −115 | −112 |
| EBIT | 4 400 | 4 789 | 4 427 | 4 283 | 3 584 |
| Net financials | 291 | −104 | −207 | −25 | 791 |
| Profit before tax | 4 691 | 4 685 | 4 221 | 4 258 | 4 375 |
| Tax | 967 | 1 080 | 981 | 947 | 960 |
| Net profit | 3 724 | 3 605 | 3 240 | 3 311 | 3 415 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4 996 | 10 495 | 11 260 | 14 015 | 17 142 |
| Equity | 1 569 | 5 174 | 8 414 | 11 725 | 15 140 |
| Long-term debt | 0 | 2 | 0 | 0 | 0 |
| Short-term debt | 3 428 | 5 320 | 2 847 | 2 290 | 2 002 |
| Total debt | 3 428 | 5 322 | 2 847 | 2 290 | 2 002 |
EBITDA margin
52.8%
This company
15.8%
Market median
+234% vs market
20202024
Equity ratio
88.3%
This company
38.2%
Market median
+131% vs market
20202024
Return on equity
22.6%
This company
18.4%
Market median
+23% vs market
20202024
Net profit margin
48.8%
This company
8.1%
Market median
+502% vs market
20202024
Asset turnover
0.41×
This company
1.12×
Market median
-63% vs market
20202024
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Chairman | 2019 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Conmed As
FREDRIKSTAD HJERTESENTER AS Board members of FREDRIKSTAD HJERTESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Archana Sharma | Board of Directors | 0 companies |
| Usha Rani Sharma | Board of Directors | 0 companies |
| Kapil Kishore Sharma | Chairman | 0 companies |
| Geeta Gulati | Board of Directors | 0 companies |
| Jugal Kishore Sharma | Board of Directors | 0 companies |